Immediate Impact
1 from Science/Nature 79 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Elmer Schabel being referenced
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum
2020
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Elmer Schabel | 230 | 119 | 9 | 100 | 8 | 260 | |
| K. Huber | 199 | 90 | 105 | 9 | 276 | ||
| Shui-Xian Du | 288 | 136 | 104 | 10 | 313 | ||
| V. Vero | 192 | 72 | 7 | 74 | 12 | 332 | |
| Anita Arslanow | 224 | 153 | 1 | 70 | 15 | 255 | |
| Helene Gellert‐Kristensen | 221 | 89 | 113 | 7 | 254 | ||
| Ruth Sargent | 261 | 114 | 164 | 6 | 301 | ||
| Hans-Jörg Cordes | 240 | 103 | 1 | 133 | 5 | 258 | |
| Koichiro Kusumoto | 230 | 132 | 67 | 6 | 267 | ||
| Anjali Deshpande | 254 | 103 | 1 | 149 | 12 | 309 | |
| Mamie H. Dong | 222 | 130 | 6 | 84 | 8 | 332 |
All Works
Loading papers...